Suppr超能文献

表达膜巨噬细胞集落刺激因子的活T9胶质瘤细胞通过“副凋亡”诱导途径,促使多形核白细胞和巨噬细胞立即破坏肿瘤,该途径可增强针对颅内T9胶质瘤的全身免疫。

Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9 gliomas.

作者信息

Chen Yijun, Douglass Thomas, Jeffes Edward W B, Xu Qingcheng, Williams Christopher C, Arpajirakul Neary, Delgado Christina, Kleinman Michael, Sanchez Ramon, Dan Qinghong, Kim Ronald C, Wepsic H Terry, Jadus Martin R

机构信息

Diagnostic and Molecular Health Care Group, Veterans Affairs Medical Center, Long Beach, CA 90822, USA.

出版信息

Blood. 2002 Aug 15;100(4):1373-80. doi: 10.1182/blood-2002-01-0174.

Abstract

Cloned T9-C2 glioma cells transfected with membrane macrophage colony-stimulating factor (mM-CSF) never formed subcutaneous tumors when implanted into Fischer rats, whereas control T9 cells did. The T9-C2 cells were completely killed within 1 day through a mechanism that resembled paraptosis. Vacuolization of the T9-C2 cell's mitochondria and endoplasmic reticulum started within 4 hours after implantation. By 24 hours, the dead tumor cells were swollen and terminal deoxynucleotide transferase-mediated dUTP nick-end labeling (TUNEL)-positive. Bcl2-transduced T9-C2 cells failed to form tumors in rats. Both T9 and T9-C2 cells produced cytokine-induced neutrophil chemoattractant that recruited the granulocytes into the tumor injection sites, where they interacted with the tumor cells. Freshly isolated macrophages killed the T9-C2 cells in vitro by a mechanism independent of phagocytosis. Nude athymic rats treated with antiasialo GM1 antibody formed T9-C2 tumors, whereas rats treated with a natural killer cell (NK)-specific antibody failed to form tumors. When treated with antipolymorphonuclear leukocyte (anti-PMN) and antimacrophage antibodies, 80% of nude rats formed tumors, whereas only 40% of the rats developed a tumor when a single antibody was used. This suggests that both PMNs and macrophages are involved in the killing of T9-C2 tumor cells. Immunocompetent rats that rejected the living T9-C2 cells were immune to the intracranial rechallenge with T9 cells. No vaccinating effect occurred if the T9-C2 cells were freeze-thawed, x-irradiated, or treated with mitomycin-C prior to injection. Optimal tumor immunization using mM-CSF-transduced T9 cells requires viable tumor cells. In this study optimal tumor immunization occurred when a strong inflammatory response at the injection of the tumor cells was induced.

摘要

转染膜巨噬细胞集落刺激因子(mM-CSF)的克隆T9-C2胶质瘤细胞植入Fischer大鼠后从未形成皮下肿瘤,而对照T9细胞则会形成。T9-C2细胞在1天内通过一种类似副凋亡的机制被完全杀死。植入后4小时内,T9-C2细胞的线粒体和内质网开始空泡化。到24小时时,死亡的肿瘤细胞肿胀且末端脱氧核苷酸转移酶介导的dUTP缺口末端标记(TUNEL)呈阳性。转导Bcl2的T9-C2细胞在大鼠体内未能形成肿瘤。T9和T9-C2细胞均产生细胞因子诱导的中性粒细胞趋化因子,该趋化因子将粒细胞募集到肿瘤注射部位,在那里它们与肿瘤细胞相互作用。新鲜分离的巨噬细胞在体外通过一种不依赖吞噬作用的机制杀死T9-C2细胞。用抗唾液酸GM1抗体处理的无胸腺裸鼠形成了T9-C2肿瘤,而用自然杀伤细胞(NK)特异性抗体处理的大鼠未能形成肿瘤。当用抗多形核白细胞(抗PMN)和抗巨噬细胞抗体处理时,80%的裸鼠形成肿瘤,而单独使用一种抗体时只有40%的大鼠发生肿瘤。这表明PMN和巨噬细胞均参与了T9-C2肿瘤细胞的杀伤。排斥活T9-C2细胞的免疫活性大鼠对T9细胞的颅内再次攻击具有免疫力。如果T9-C2细胞在注射前进行冻融、X射线照射或用丝裂霉素-C处理,则不会产生疫苗接种效果。使用mM-CSF转导的T9细胞进行最佳肿瘤免疫需要活的肿瘤细胞。在本研究中,当在注射肿瘤细胞时诱导强烈的炎症反应时发生了最佳肿瘤免疫。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验